MSH|^~\&|LAB|CGH|||201912310950||ORU^R01|4137270|D|2.3|||AL|NE
PID|1||CG00002212|CG2180|PHATEST^ECU^|||F||||||||||CG000173/18|
OBR|1|37354^LAB|00028083^3112:C00003R^LAB^311219:C3^37354|531.3800^DIG^Digoxin Level^^^14698-5||201912310950|201912310900|||||||201912310950||||||||||LAB|F||||
OBX|1|ST|531.3900^DIG R^Digoxin^^14698-5^14698-5|1|2.7^^Y|nmol/L|0.6-2.6|H||A^S|F|||201912310950
NTE|1||Risk of Digoxin Toxicity increases with increasing levels.
NTE|2||Optimal Therap. Range for Heart Failure 0.7 - 1.3 nmol/L
NTE|3||Therap. Range for Atrial Fibrillation not well established.
NTE|4||Method:Beckman Access/DxI